Tag: pharmaceuticals

Pills or Prevention The Real Fight Against Obesity

Pills or Prevention The Real Fight Against Obesity

The excitement over the new miracle weight loss drugs is surely overwhelming your ears. Promising quick results, these drugs are rapidly gaining traction, fueled by aggressive marketing and the desperation of millions struggling with obesity. A crucial question lingers: Are we prioritizing a quick fix over sustainable, long-term solutions? I’m...

Tariff Mirage: Why Protectionism Won't Save American Manufacturing

Tariff Mirage: Why Protectionism Won't Save American Manufacturing

The appeal of tariffs is seductive. We support the promise of safeguarding American manufacturers from foreign competition! It provides an opportunity to strengthen domestic supply chains and reshore jobs, more important now than ever in a world of rising economic uncertainty. As a journalist steeped in the nuances of trade...

Shielding America: The Case for Strategic Tariffs on Autos and Pharma

Shielding America: The Case for Strategic Tariffs on Autos and Pharma

The global economy is a labyrinth of rapidly shifting interrelated markets. As a dominant small-c coastal power, the United States needs to be careful how it sails these waters in order to protect its interests. We have a largely overlooked but powerful tool at our disposal—tariffs, or taxes on imported...

Eli Lilly's Orforglipron Poised to Revolutionize Weight Loss Treatment with Oral Pill

Eli Lilly's Orforglipron Poised to Revolutionize Weight Loss Treatment with Oral Pill

Meanwhile, Eli Lilly is set to announce the first results from late-stage clinical trials for its experimental once-daily obesity pill, orforglipron. How this breakthrough could change the way we treat weight loss! The pharmaceutical giant’s quest for an oral alternative to injectable weight loss drugs such as Wegovy and Zepbound...

Trump Hints at Forthcoming Tariffs on Autos, Pharma Amid Trade Policy Jitters

Trump Hints at Forthcoming Tariffs on Autos, Pharma Amid Trade Policy Jitters

President Donald Trump announced Monday that tariffs targeting automobiles, pharmaceuticals, and other industries would be revealed soon, creating uncertainty in international trade relations. He delivered his comments at a Cabinet meeting earlier this week. This came just hours after he released a different plan to slap 25% tariffs on every...

AstraZeneca's Asian Ascent: A New Chapter for Global Pharma

AstraZeneca's Asian Ascent: A New Chapter for Global Pharma

The pharmaceutical industry faces a period of seismic change, with much of the movement and play taking place in Asia. AstraZeneca’s recent performance and strategic moves paint a vivid picture of this trend. The company’s annual revenues exploded by an extraordinary 21%, soaring to £43 billion ($54.1 billion). This rapid...

AstraZeneca Pledges $2.5 Billion Investment in Beijing R&D Hub

AstraZeneca Pledges $2.5 Billion Investment in Beijing R&D Hub

British pharma-bulldozer AstraZeneca will pump $2.5 billion into a new research and development (R&D) hub. To be part of this ambitious journey that will lead to Beijing. This latest strategic move further highlights WuXi’s conviction to increase its foothold within China and continue to foster new, cutting-edge medicines. The Beijing...